/ /


Investigational trials target VEGF/angiopoietin2 inhibition
Bascom Palmer takes top honors in Ophthalmology Times Best Programs SurveyAfter a seven-year hiatus, Ophthalmology Times resumed its Best Programs Survey this fall. While a few new names popped up on the list, Bascom Palmer Eye Institute at the University of Miami Miller School of Medicine, Miami, remained at the top of the Best Overall Program category, followed again by the Wilmer Eye Institute at the Johns Hopkins University School of Medicine, Baltimore. Number three in the overall list has a new name with Dean McGee Eye Institute at the University of Oklahoma, Oklahoma City—the first time that institute has appeared in the top category since the survey’s inception 20 years ago.
Povidone iodine reapplication: Protocol for preventing endophthalmitisTake-Home Message: A pearl for preventing endophthalmitis following intravitreal injections: avoid eyelid contact with the injection site after the last application of povidone iodine.
Glaucoma 360 annual meeting will celebrate, innovate, educate in 2018
Fillers 101: Foundations for successThe foundations for success in using fillers during oculofacial surgery include understanding the characteristics of these products, which influences outcomes, and learning techniques to avoid and treat complications.
Cataract meeting outgrows Naples, moves to Amelia Island in 2018
Facial shaping with fillers an ‘artform’
Outcomes differ from trials with ‘real-world’ anti-VEGF therapy for DMEThe visual outcomes after anti-VEGF therapy administered to treat diabetic macular edema in the “real world” do not achieve those reported in randomized clinical trials. Eyes with better baseline visual acuity are disproportionately affected.
Techniques for lacrimal canalicular lacerations steadily improving
Have we dodged another Zika bullet?Now with mosquito season past in most parts of North America, it seems we can be confident the predicted spread will not come to pass—at least in this year.


View Results